The summer and fall of 2014 have been a season of surrogacy scandals revealed. Media reports describe disturbing practices taking place in one country after another, including Thailand, Australia, China, and Mexico.
A front-page series in The New York Times by Tamar Lewin seemed to kick off a run of high-profile coverage. Lewin’s lengthy July 5 story focuses on people who come to the US for contract pregnancies because their own countries prohibit them. It gives plenty of play to surrogacy “success stories,” but also includes sharply critical comments by women’s health advocates from Canada and Germany, neither of which permit commercial surrogacy.
“Just like we don’t pay for blood or semen, we don’t pay for eggs or sperm or babies,” said Abby Lippman, an emeritus professor at McGill University in Montreal who studies reproductive technology. “There’s a very general consensus that paying surrogates would commodify women and their bodies. I think in the United States, it’s so consumer-oriented, so commercially oriented, so caught up in this ‘It’s my right to have a baby’ approach, that people gloss over some big issues.”
“We regard surrogacy as exploitation of women and their reproductive capacities,” [said Dr. Ingrid Schneider of the University of Hamburg’s Research Center for Biotechnology, Society and the Environment].
On July 27, Lewin followed up with another front-page feature, this one about the notorious Los Angeles-based surrogacy agency Planet Hospital, which recently declared bankruptcy after defrauding dozens of intending parents and women working as surrogate mothers.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.